Pura Vida Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-24,246
Closed -$1.86M 264
2021
Q4
$1.86M Sell
24,246
-60,754
-71% -$4.84M 0.07% 151
2021
Q3
$6.38M Buy
+85,000
New +$6.46M 0.19% 130
2020
Q3
Sell
-72,437
Closed -$5.34M 169
2020
Q2
$5.34M Buy
+72,437
New +$5.45M 0.51% 47
2018
Q3
Sell
-31,440
Closed -$1.82M 122
2018
Q2
$1.82M Sell
31,440
-73,360
-70% -$4.14M 0.73% 52
2018
Q1
$5.45M Buy
+104,800
New +$5.66M 3.22% 8
2017
Q4
Sell
-161,989
Closed -$9.9M 88
2017
Q3
$9.9M Buy
161,989
+25,749
+19% +$1.56M 2.9% 6
2017
Q2
$8.33M Buy
+136,240
New +$8.29M 3.31% 7

Other funds holding MRK

Pura Vida Investments's MRK Position: Q1 2022 in Review

Pura Vida Investments sold out of Merck (MRK) in Q1 2022, closing a stake of 24,246 shares — an estimated $1.86M sold.

Pura Vida Investments first reported a position in MRK in Q2 2017 and held it in 7 quarters. The position peaked at $9.9M in Q3 2017. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Pura Vida Investments reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 24,246 Merck shares in Q1 2022, an estimated $1.86M.
  • Pura Vida Investments first reported a position in Merck in Q2 2017 and held it in 7 quarters.
  • Pura Vida Investments's Merck position peaked at $9.9M in Q3 2017.
  • 2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.